BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34315208)

  • 1. Increased Mortality in Young-Onset Parkinson's Disease.
    Hustad E; Myklebust TÅ; Gulati S; Aasly JO
    J Mov Disord; 2021 Sep; 14(3):214-220. PubMed ID: 34315208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Queensland Parkinson's Project: An Overview of 20 Years of Mortality from Parkinson's Disease.
    Poortvliet PC; Gluch A; Silburn PA; Mellick GD
    J Mov Disord; 2021 Jan; 14(1):34-41. PubMed ID: 33278869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age Cutoff for Early-Onset Parkinson's Disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's Disease.
    Mehanna R; Smilowska K; Fleisher J; Post B; Hatano T; Pimentel Piemonte ME; Kumar KR; McConvey V; Zhang B; Tan EK; Savica R;
    Mov Disord Clin Pract; 2022 Oct; 9(7):869-878. PubMed ID: 36247919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival in patients with Parkinson's disease: a ten-year follow-up study in northern China.
    Wang S; Li T; Zhou T; Pu L; Wang HY; Yin X; Hao X; Ren L; Liang Z
    BMC Neurol; 2022 Sep; 22(1):367. PubMed ID: 36138355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The estimated life expectancy in a community cohort of Parkinson's disease patients with and without dementia, compared with the UK population.
    Hobson P; Meara J; Ishihara-Paul L
    J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1093-8. PubMed ID: 20571039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease.
    Kandiah N; Zhang A; Cenina AR; Au WL; Nadkarni N; Tan LC
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1145-8. PubMed ID: 25176439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing the development of early- or late-onset Parkinson's disease in a cohort of South African patients.
    van der Merwe C; Haylett W; Harvey J; Lombard D; Bardien S; Carr J
    S Afr Med J; 2012 Oct; 102(11 Pt 1):848-51. PubMed ID: 23116741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive profile of Parkinson's disease patients: a comparative study between early-onset and late-onset Parkinson's disease.
    Tang H; Huang J; Nie K; Gan R; Wang L; Zhao J; Huang Z; Zhang Y; Wang L
    Int J Neurosci; 2016; 126(3):227-34. PubMed ID: 26001202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality in Parkinson's disease: a 20-year follow-up study.
    Diem-Zangerl A; Seppi K; Wenning GK; Trinka E; Ransmayr G; Oberaigner W; Poewe W
    Mov Disord; 2009 Apr; 24(6):819-25. PubMed ID: 19224612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality from Parkinson's disease in China: Findings from a ten-year follow up study in Shanghai.
    Zhang Y; Wang C; Wang Y; Xiao Q; Liu J; Ma J; Zhou H; Pan J; Tan Y; Chen S; Xu G; Wang G
    Parkinsonism Relat Disord; 2018 Oct; 55():75-80. PubMed ID: 29802079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Modifying Effect of Age on Survival in Parkinson's Disease: A Population-Based Cohort Study.
    Peretz C; Rozani V; Giladi N; El-Ad B; Tsamir J; Hemo B; Gurevich T
    Neuroepidemiology; 2019; 53(1-2):13-19. PubMed ID: 31203291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease patients first treated at age 75 years or older: a comparative study.
    Peretz C; Chillag-Talmor O; Linn S; Gurevich T; El-Ad B; Silverman B; Friedman N; Giladi N
    Parkinsonism Relat Disord; 2014 Jan; 20(1):69-74. PubMed ID: 24183677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
    Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
    Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What predicts mortality in Parkinson disease?: a prospective population-based long-term study.
    Forsaa EB; Larsen JP; Wentzel-Larsen T; Alves G
    Neurology; 2010 Oct; 75(14):1270-6. PubMed ID: 20921512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of event-free survival at 12 and 24 months and long-term mortality for non-Hodgkin follicular lymphoma patients: A study report from the Spanish Lymphoma Oncology Group.
    Provencio M; Royuela A; Torrente M; Pollán M; Gómez-Codina J; Sabín P; Llanos M; Gumá J; Quero C; Blasco A; Aguiar D; García-Arroyo FR; Lavernia J; Martínez N; Morales M; Saenz-Cusi Á; Rodríguez D; Calvo V; de la Cruz-Merino L; de la Cruz MÁ; Rueda A;
    Cancer; 2017 Oct; 123(19):3709-3716. PubMed ID: 28608996
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Sasannezhad P; Juibary AG; Sadri K; Sadeghi R; Sabour M; Kakhki VRD; Alizadeh H
    Asia Ocean J Nucl Med Biol; 2017; 5(2):114-119. PubMed ID: 28660222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality in Parkinson's disease: a 38-year follow-up study.
    Pinter B; Diem-Zangerl A; Wenning GK; Scherfler C; Oberaigner W; Seppi K; Poewe W
    Mov Disord; 2015 Feb; 30(2):266-9. PubMed ID: 25447933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort.
    Croxford S; Kitching A; Desai S; Kall M; Edelstein M; Skingsley A; Burns F; Copas A; Brown AE; Sullivan AK; Delpech V
    Lancet Public Health; 2017 Jan; 2(1):e35-e46. PubMed ID: 29249478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Best early-onset Parkinson dementia predictor using ensemble learning among Parkinson's symptoms, rapid eye movement sleep disorder, and neuropsychological profile.
    Byeon H
    World J Psychiatry; 2020 Nov; 10(11):245-259. PubMed ID: 33269221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting cognitive decline with non-clinical markers in Parkinson's disease (PRECODE-2).
    Yousaf T; Pagano G; Niccolini F; Politis M
    J Neurol; 2019 May; 266(5):1203-1210. PubMed ID: 30820739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.